chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administered vaccine after 33 days in the refrigerator; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Oct-2021 and was forwarded to Moderna on 19-Oct-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. The treatment information was unknown.
On Tuesday evening start out with swollen arm, vomiting, headaches, chills, temp and body aches. Arm is still swollen with area still red and lump in arm.
Baby was administered Pediarix and Hib mixed in the same syringe, instead as two different injections.  No adverse effects noted.
Myalgia, Arthralgia, Fever, CoughWheeze, NauseaVomiting, Syncope, chills, fatigue Narrative: Coughing, fever Tmax 100.2, chills, nausea, fatigue, myalgia, arthralgia; no SOA.
This spontaneous report was received from a certified medical assistant and refers to multiple unspecified patients of unknown age and gender. The patients' pertinent medical histories and drug reactions or allergies were not reported. On multiple unspecified dates, the patients were vaccinated with improperly stored doses of M-M-R II human serum albumin (HSA) injection, lot # M032485, expiration date 06-JUL-2018 (dose, route and site of administration were not reported), which were reconstituted with properly stored sterile diluent (MERCK). No adverse effects were reported. Product quality complaint was not involved. The administered doses of M-M-R II were stored in the temperature between 47 degrees Fahrenheit and 77 degrees Fahrenheit, for 1 hour and subsequently for 30 minutes. Data logger was involved. No further information was provided.
Possible severe adverse event.  Patient stated he got the Pfizer COVID-19 vaccination in October and believes he may have had COVID-19 infection around the holidays (he was symptomatic after direct exposure but was never tested.)  Symptoms resolved however on 1/24 patient presented to the ER at the Hospital with epigastric and lower abdominal pain and a low POX.  Workup revealed extensive clotting  burden, including bilateral massive pulmonary emboli with saddle embolus, a splenic infarct, a kidney infarct and clot in his SMA.  No history of clotting issues and no known family hx of blood disorders.  No other obvious risk factors.
Shingles attack 13 days post vaccination (first ever). Now 17 days old.
hives all over, continuing today ( 5 weeks). Seen allergist and dermatologist, had extensive bloodwork,   Currently taking 40mg Prednisone for one week, also doxepin and atarax.
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 6/28/2022 C DIFFICILE INFECTION
J96.00 ACUTE RESPIRATORY FAILURE 12/13/2022 COVID-19 PNEUMONIA R09.02 HYPOXIA 11/10/2022 COVID-19 PNEUMONIA J96.00 ACUTE RESPIRATORY FAILURE 12/13/2022 NONTRAUMATIC ACUTE KIDNEY INJURY R09.02 HYPOXIA 11/10/2022 NONTRAUMATIC ACUTE KIDNEY INJURY J96.00 ACUTE RESPIRATORY FAILURE 12/13/2022 ACUTE RESPIRATORY FAILURE R09.02 HYPOXIA 11/10/2022 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 12/13/2022 ELEVATED TROPONIN I R09.02 HYPOXIA 11/10/2022 ELEVATED TROPONIN I
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Hypertension-Severe
Muscle aching, chills, dyspepsia, headache and stiff neck. Achiness in arms and hands to where she could not grip. Consulted chiropractor on 12/16/00, MD on 12/18/00 and Massage Therapist on 12/20/00. By 12/21/00, symptoms eased.
rash on arms, back, abdomen and legs.  pt went to the ER and received a tapering does of prednisone 30 mg a day for 2 days and then 20 mg a day for 2 days then 10 mg a day for 2 days.  also recommended over-the-counter med every 6 hours (ER report does not state what OTC med she was supposed to get)
Moderate muscle aches X12 hours, moderate headache  X 12 hours, and fatigue X 12  hours
child diagnosed with chicken pox, onset of symptoms 10/07/2005. Child previously had varivax 08/12/03. Vaccine failure.
Patient received the flu vaccine at Employee Health by this writer as he does every year. This writer monitored him for 10-12 minutes with no reaction observed or reported. Patient returned less than 10 min after reporting feeling itchy on his upper extremities, scratching, leaving marks on his skin "dermatographia". Denied any difficulty breathing, no respiratory distress noted, no other symptoms reported other than itchiness. He reports he had this happened before for a while in the past year, but didn't know the cause. This writer offered Benadryl PO at that time, but he wanted to wait if it resolved on its own. The itchiness subsided and skin redness was gone within an hour without any antihistamines.
This morning I woke up and have 2 swollen lymph nodes at the base of my neck on the same side as the vaccine was given. They do not hurt, aren't red or tender, just swollen.
Pt. told dad she was dizzy and had syncopal event x 2 seconds- was pale and sweaty- had pt lie down w/HOB elevated- gave water, took vitals, and monitored x 20-25 min and checked by Dr.
A company representative reported that a 20 month old male received a 4th dose of Prevnar vaccine in August 2002, at the age of 15 months. Medical history included "developmentally slow" and surgery for 6th nerve paralysis in March 2002, which occurred 2 days after he received his 3rd dose of Prevnar (see related report IDHQWYE029327JAN03). On 12/18/02, he received diphtheria and tetanus toxoids and acellular pertussis vaccine (manuf unk), polio vaccine and haemophilus B conjugate vaccine (manuf unk). In January 2003, at the age of 20 months, he experienced a 2nd episode of 6th nerve paralysis in the optic nerve. It was reported that "the pt's eyes are crossed again." No further info was available at the date of this report. Additional info received by telephone message on 1/30/03, from the company representative, revealed a vaccine that began with a "P," possibly Prevnar. The physician did not think the paralysis was vaccine-related, but perhaps due to a "virus." It was felt that the Prevnar had "nothing to do with the child's 6th nerve paralysis." The physician, his staff, and the mother of the child "do not wish to pursue this speculation, nor be called on or contacted."
Multiple circular vesicular lesions on the arm that influenza vaccine was given. These lesions also had an impetigous component to them. Right axillary node also.
Pt recvd 1st Engerix-B vax for prevention of Hep B infect in JUN91; pt exp flu-like sx, h/a, & nausea 12 hrs post vax; tx Advil & anaprox w/o much relief;
Chills and fever (max 100.9), pain at injection site about 18 hours duration, took Tylenol 500 mg x 2 hours apart
MADE EYEBALLS HURT, PRODUCT WAS KILLING EYES, EYES WERE GOING CRAZY; STRANGE SEVERE REACTION ABOUT 30 MINUTES POST VACCINATION; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: chemical sensitivity, and dry skin, and other pre-existing medical conditions included: The patient had no illness at the time of vaccination, no past history of similar events, no adverse event after any previous vaccinations, no pre existing acute illness 30 days prior to vaccination, no history of hospitalization in last 30 days. The patient was not pregnant at the time of vaccination and was not currently breastfeeding. The patient had no needle phobia or fear of vaccines. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 03-MAY-2021 for covid-19 prophylaxis. Age at time of vaccination 66 years old. No concomitant medications were reported. On 03-MAY-2021, the patient experienced strange severe reaction about 30 minutes post vaccination. The patient received neutrogena hydro boost gel-cream extra-dry skin (cream, topical, batch number: 11622VB1 expiry: UNKNOWN) dose and frequency were not reported from 01-FEB-2023 for dry skin.  On FEB-2023, the patient experienced made eyeballs hurt, product was killing eyes, eyes were going crazy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with neutrogena hydro boost gel-cream extra-dry skin was not reported. The patient recovered from made eyeballs hurt, product was killing eyes, eyes were going crazy, and the outcome of strange severe reaction about 30 minutes post vaccination was not reported. This report was non-serious.
under arm pain (lymph node); headache; This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (under arm pain (lymph node)) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (She is a Breast cancer Survivor .).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced LYMPH NODE PAIN (under arm pain (lymph node)) and HEADACHE (headache). At the time of the report, LYMPH NODE PAIN (under arm pain (lymph node)) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-016238 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-016238:
No SSx reported. Pt was given 2nd Flu vaccine by mistake. 1st FLUZONE given 10/2015. 2nd high dose given 12/29/15.
cough; she couldn't lift her head; had muscle aches and pains; weakness; a splitting headache; couldn't move; chills; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 62; unit unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 31Jan2021 11:15 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got the vaccine on Sunday 31Jan2021 at 11:15 and felt good all day. But the next day on 01Feb2021, she couldn't lift her head, had muscle aches and pains, weakness and a splitting headache. She couldn't move. She had chills but no fever measured by a forehead thermometer.  She was feeling a bit better ton 02Feb2021 but still has chills and had a cough that was escalating. Patient was asking if she gets the second one, will she have the same reaction. Outcome of the event of chills was not recovered , for cough was unknown while for the remaining events was recovering  Information on the lot/batch number has been requested.
Aching joints, muscles, shivering cold, stomach ache, nausea, diarrea, tiredness.
Weakness, pain in shoulders and hips. Abnormal feeling - could not lay on one side for more than an hour or so. Onset the night of vaccination and resolved by 6pm the following day.
Strange odor a few minutes after injection, followed by bitter taste, then nausea and spaciness. Dizzyness, with vision looking 2D and flat by 15 minutes. Told Pharmacist, of spaciness who said stay as long as I wanted. Left at 30 minute point, still spacy and nauseous. Spaciness ended by an hour with nausea off and on. Chest pain - began around 7pm, continued to expand in area of chest, sharp stabbing pain later, pain from just above left elbow to hand and tingling of fingers, pain lower left leg and tingling of left foot. Irregular heart rate at different times. Checked into emergency room at 11:00. IV inserted, placed on continual heart and oxygen monitors, EKGs, chest X-rays (2), blood tests (3). Admitted to hospital sometime during the night. Given IV medications to counteract IV contrast allergy. These medications caused full body shakes, eyesight auras and extreme nausea with gagging. Heart CT taken with IV contrast. Discharged around 3:00 PM.
Sore throat, fever 99.8, muscle aches (sore throat is not listed as normal side effect on information form)
Redness, swelling, pain, warm to the touch, itching at the injection site 8 days after injection was administered
Redness, swelling, pain at injection site lasting more than 4 days, fatigue.
Lost all ability to sit upright; Lost ability to stand; Lost ability to walk; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic depression and known allergies to antibiotics. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 24Feb2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 17Mar2021 at 18:00, the patient lost all ability to sit upright, lost ability to stand and lost ability to walk, which lasted about 14 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lost all ability to sit upright, lost ability to stand and lost ability to walk was recovered with sequelae on 18Mar2021.  No follow-up attempts are possible. No further information is expected.
A couple of weeks after receiving my vaccination, I had mild symptoms of sore throat, light cough, and a slight fever. My symptoms only lasted 2-3 days after. I had some pressure/swelling in my eye but disregarded it. But a month later, I started having random eye issues. My vision would blur and flashing lights would trouble my vision. I went to see a retinol specialist to see what was wrong with my left eye. He dilated my pupils and examined my eyes and saw a tear in the vitreous (vitreous detachment) of my eye and was close to damaging the retina. He made a follow-up appointment and has continued to make follow-up appointments (one coming up in July) to check the progression/healing of the detachment and ensure it isn't getting worse.
Can still feel a little pinch like a sensation if she pushes down on that area; not feeling like her self; completely drained; arm real sore for about 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm real sore for about 4 days), FEELING ABNORMAL (Can still feel a little pinch like a sensation if she pushes down on that area), FEELING ABNORMAL (not feeling like her self) and FATIGUE (completely drained) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included METFORMIN and SIMVASTATIN for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm real sore for about 4 days). On an unknown date, the patient experienced FEELING ABNORMAL (Can still feel a little pinch like a sensation if she pushes down on that area), FEELING ABNORMAL (not feeling like her self) and FATIGUE (completely drained). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm real sore for about 4 days), FEELING ABNORMAL (Can still feel a little pinch like a sensation if she pushes down on that area), FEELING ABNORMAL (not feeling like her self) and FATIGUE (completely drained) had resolved.            Concomitant product included blood pressure medications. Treatment information included Tylenol 3 or 4 times.
Immediately after injection patient experienced a swollen hardened bump and bruising at the injection site. She said she felt fine and that it was not painful. She also said she bruises easily. She was not concerned at the time of the injection. I called her at home later in the day to follow up with her and she said she was doing fine. She said it was still not painful and she felt well. She said the swelling had gone down some and she did not experience any other issues.
Coughing; Sore throat; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing) and OROPHARYNGEAL PAIN (Sore throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Coughing) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, COUGH (Coughing) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant product use was reported.  No treatment details were provided.
total of 4 days tired/weak, and right arm sore (from thursday through sunday) early saturday morning had 4 hours of hallucinations, nausea and extreme vomiting, dizzyness ,loss of appetite slept for 12 hours on saturday and sunday after the 4 hrs of events listed above. still weak after feeling better on sunday afternoon
Difficulty of moving or raising it; took Tylenol last night to try to calm the pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTED LIMB MOBILITY DECREASED (Difficulty of moving or raising it) and VACCINATION SITE PAIN (took Tylenol last night to try to calm the pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (Difficulty of moving or raising it) and VACCINATION SITE PAIN (took Tylenol last night to try to calm the pain). At the time of the report, INJECTED LIMB MOBILITY DECREASED (Difficulty of moving or raising it) and VACCINATION SITE PAIN (took Tylenol last night to try to calm the pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history was reported. No concomitant medications were provided.   This case was linked to MOD-2021-032043 (Patient Link).   Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
After being forced by the state, I had the Jansen vaccine. And experienced headache fatigue nausea for 3 days And emotional distress from receiving a mandated poisonous vaccine without informed consent.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Aug2021 16:00 (Batch/Lot number: unknown) at the age of 46 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "allergies" (unspecified if ongoing). Concomitant medication(s) included: MOTRIN IB. The following information was reported: CHEST DISCOMFORT (non-serious) with onset 21Aug2021 16:00, outcome "unknown", described as "My 1st shot went to my mouth and throat got swollen with sore throat, little hard to breathe, chest got tighten"; PHARYNGEAL SWELLING (non-serious) with onset 21Aug2021 16:00, outcome "unknown", described as "throat got swollen"; OROPHARYNGEAL PAIN (non-serious) with onset 21Aug2021 16:00, outcome "unknown", described as "sore throat". It was unknown if therapeutic measures were taken as a result of chest discomfort, pharyngeal swelling, oropharyngeal pain. Additional information: The facility where the most recent COVID-19 vaccine was administered was Pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Breakthrough case admission after 5 vaccines Pfizer 1/16/21 lot# EL1283;  Pfizer 2/3/21 lot#EL9265;  Pfizer 9/17/21 lot# Ew0179;  Pfizer 4/1/22 Lot# Fk9896;  Pfizer 10/7/22 lot# GJ2524;
This spontaneous case reported by a consumer, describes the occurrence of emotional distress (started feeling an emotional choked-up feeling that lasted for an hour) and anxiety (she has very bad anxiety) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 039D21A and 93990Y) for COVID-19 immunization. No medical history reported. On Aug 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Sep 28, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Sep 28, 2021, patient experienced emotional distress (started feeling an emotional choked-up feeling that lasted for an hour). On an unknown date, patient experienced anxiety (she has very bad anxiety). At the time of the report,  emotional distress (started feeling an emotional choked-up feeling that lasted for an hour) and anxiety (she has very bad anxiety) outcome: unknown. Concomitant product use and treatment information not provided.
This spontaneous report as received from a other health professional refers to patients of unknown age. On unknown dates the patient were vaccinated with GARDASIL 9 for prophylaxis. On unknown dates the patients experienced incorrect product storage. No adverse event was reported. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage to be not related to GARDASIL 9. The reporter considered no adverse event to be not related to GARDASIL 9. Additional information has been requested. Sender's Comments: US-009507513-1708USA008033.
pt recv vax 11OCT96 & w/in 1hr had numbness & tingling in lt face, arm & leg;progressed to severe vomiting;presented to ER & dx w/intercerebral bleed;MD states probably no correlation between two events, family believes vax precipitat